-
1561
Empowering India’s fight against cervical cancer: Harnessing routine HPV immunisation
Published 2025-01-01Subjects: Get full text
Article -
1562
18 YAŞ ÜSTÜ VATANDAŞLARIN COVID-19 AŞI KARŞITLIĞI NEDENLERİNİN İNCELENMESİ
Published 2022-11-01Subjects: Get full text
Article -
1563
Neutralizing antibody test supports booster strategy for young individuals after SARS-CoV-2 Omicron breakthrough
Published 2025-01-01Subjects: Get full text
Article -
1564
-
1565
Tick-borne encephalitis: students’ attitude and knowledge analysis
Published 2018-06-01Subjects: Get full text
Article -
1566
Biological properties of foot-and-mouth disease virus А 2205/G-IV strain
Published 2023-12-01Subjects: Get full text
Article -
1567
Applications of liposomes and lipid nanoparticles in cancer therapy: current advances and prospects
Published 2025-01-01Subjects: Get full text
Article -
1568
Virus-like particle: a nano-platform that delivers cancer antigens to elicit an anti-tumor immune response
Published 2025-01-01Subjects: Get full text
Article -
1569
-
1570
Establishing a new human pneumococcal standard reference serum, MPRSS-01
Published 2025-01-01Subjects: Get full text
Article -
1571
Immunoprotective effect of chitosan nanoparticles with different particle sizes against H9N2 avian influenza infection
Published 2025-01-01Subjects: Get full text
Article -
1572
-
1573
-
1574
Unraveling HPV-associated cancer complexity: From molecular insights to innovative therapies
Published 2025-02-01Subjects: Get full text
Article -
1575
Cervical cancer mortality trends in England and Poland
Published 2024-12-01Subjects: Get full text
Article -
1576
The Expressions of the Immunity- and Muscle Development-Related Genes of 40-Day-Old Broilers Are Promoted in Response to the <i>In Ovo</i> and Dietary Supplemental Administration of Calcidiol in Conjunction with the <i>In Ovo</i> Administration of Marek’s Disease Vaccine
Published 2024-12-01Subjects: Get full text
Article -
1577
-
1578
Safety and efficacy of the therapeutic DNA-based vaccine VB10.16 in combination with atezolizumab in persistent, recurrent or metastatic HPV16-positive cervical cancer: a multicenter, single-arm phase 2a study
Published 2025-01-01“…We investigated the safety, efficacy, and immunogenicity of the therapeutic DNA-based vaccine VB10.16 combined with the immune checkpoint inhibitor atezolizumab in patients with human papillomavirus (HPV)16-positive r/m cervical cancer.Patients and methods This multicenter, single-arm, phase 2a study (NCT04405349, registered 26 May 2020) enrolled adult patients with persistent, r/m HPV16-positive cervical cancer. …”
Get full text
Article -
1579
Real-world effectiveness and causal mediation study of BNT162b2 on long COVID risks in children and adolescentsResearch in context
Published 2025-01-01Subjects: Get full text
Article -
1580